STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB) announces that the company’s CEO, Niklas Prager, has bought 23,600 class B shares in Medivir at an acquisition price of approximately SEK 2.1 million. The share purchase has occurred within the framework of an insurance arrangement and will consequently be made public through this press release and not be reported to the Swedish Financial Supervisory Authority’s insider register.
Help employers find you! Check out all the jobs and post your resume.
